Exploration of the anti-depressant potential of L-dopa.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D003863:Depression / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D005263:Femoral Artery; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D015016:Yohimbine / Q000494:pharmacology
D000928:Antidepressive Agents; D015016:Yohimbine; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D006220:Haloperidol; D007099:Imipramine